COVID-19: PCORI-funded study to assess antimalarial drug’s ability to prevent coronavirus infection

WASHINGTON (April 1, 2020) – The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved up to $50 million to fund a registry and randomized clinical trial of the effectiveness of hydroxychloroquine (HCQ) in preventing COVID-19 infections in U.S. healthcare workers. The registry will create a community of healthcare workers (HCWs) interested in contributing…

Outcomes of coronavirus patients treated with extracorporeal membrane oxygenation in China offers guidance for management of critically ill COVID-19 patients worldwide

April 1, 2020 – The initial experience of extracorporeal membrane oxygenation (ECMO) management for coronavirus 2019 (COVID-19) patients in Shanghai, China provides guidance for management of critically ill COVID-19 patients worldwide, reports a study in the ASAIO Journal. The journal is published in the Lippincott portfolio by Wolters Kluwer. For the most critically ill COVID-19…